Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,521 to 1,540 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The tumor-targeted CD40 agonist CEA-CD40 promotes T cell priming via a dual mode of action by increasing antigen delivery to dendritic cells and enhancing their activation. | J Immunother Cancer | 2022 | 35292514 | PubTator, text mining | PubMed |
| Messenger RNA vaccines for cancer immunotherapy: progress promotes promise. | J Clin Invest | 2022 | 35289317 | PubTator, text mining | PubMed |
| CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma. | J Pathol Clin Res | 2022 | 35289116 | PubTator, text mining | PubMed |
| Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. | Commun Biol | 2022 | 35288635 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine development. | Cancer Med | 2022 | 35285582 | PubTator, text mining | PubMed |
| Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer. | Front Genet | 2022 | 35281822 | PubTator, text mining | PubMed |
| A Novel Ras--Related Signature Improves Prognostic Capacity in Oesophageal Squamous Cell Carcinoma. | Front Genet | 2022 | 35281814 | PubTator, text mining | PubMed |
| Glycosylation-Related Genes Predict the Prognosis and Immune Fraction of Ovarian Cancer Patients Based on Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning. | Oxid Med Cell Longev | 2022 | 35281472 | PubTator, text mining | PubMed |
| Transcriptional Expressions of ALDH1A1/B1 as Independent Indicators for the Survival of Thyroid Cancer Patients. | Front Oncol | 2022 | 35280765 | PubTator, text mining | PubMed |
| A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma. | BMC Cancer | 2022 | 35279104 | PubTator, text mining | PubMed |
| Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors. | Oncologist | 2022 | 35278076 | PubTator, text mining | PubMed |
| Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma. | Bosn J Basic Med Sci | 2022 | 35276059 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. | Int J Mol Sci | 2022 | 35269922 | PubTator, text mining | PubMed |
| Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment. | Int J Mol Sci | 2022 | 35269652 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Prognosis and Drug Sensitivity of Differentiation-Related lncRNAs in Papillary Thyroid Cancer. | Cancers (Basel) | 2022 | 35267662 | PubTator, text mining | PubMed |
| Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. | Cancers (Basel) | 2022 | 35267611 | PubTator, text mining | PubMed |
| Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy. | Cancers (Basel) | 2022 | 35267567 | PubTator, text mining | PubMed |
| Emerging CAR T Cell Strategies for the Treatment of AML. | Cancers (Basel) | 2022 | 35267549 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets. | Cancers (Basel) | 2022 | 35267539 | PubTator, text mining | PubMed |
| Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy. | Cancers (Basel) | 2022 | 35267473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=77